- Filed
- Jan 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jan 3, 2025 | 6.47M sh |
| Long Term Debt | Q2 2025 · Nov 30, 2024 | $143.34K |
| Cash And Equivalents | Q2 2025 · Nov 30, 2024 | $5.21M |
| Cash And Equivalents | Q2 2025 · May 31, 2024 | $3.25M |
| Current Liabilities | Q2 2025 · Nov 30, 2024 | $4M |
| Current Liabilities | Q2 2025 · May 31, 2024 | $2.8M |
| Total Liabilities | Q2 2025 · Nov 30, 2024 | $4.89M |
| Total Liabilities | Q2 2025 · May 31, 2024 | $3.28M |
| Current Assets | Q2 2025 · Nov 30, 2024 | $10.05M |
| Current Assets | Q2 2025 · May 31, 2024 | $7.97M |
| Total Assets | Q2 2025 · Nov 30, 2024 | $13.71M |
| Total Assets | Q2 2025 · May 31, 2024 | $10.97M |
| Shares Diluted restated | Q2 2025 · Nov 30, 2023 | 18.63M sh |
| Shares Diluted restated | Q2 2025 · Nov 30, 2023 | 18.63M sh |
| Capex | Q2 2025 · Nov 30, 2023 | $70.85K |
| Operating Cash Flow | Q2 2025 · Nov 30, 2023 | $1.25M |
| Stockholders Equity | Q2 2025 · Nov 30, 2023 | $7.95M |
| Stockholders Equity | Q2 2025 · Aug 31, 2023 | $6.88M |
| Stockholders Equity | Q2 2025 · May 31, 2023 | $6.67M |
| Eps Diluted restated | Q2 2025 · Nov 30, 2023 | $0.05 |
| Eps Diluted restated | Q2 2025 · Nov 30, 2023 | $0.06 |
| Eps Basic restated | Q2 2025 · Nov 30, 2023 | $0.17 |
| Eps Basic restated | Q2 2025 · Nov 30, 2023 | $0.20 |
| Sga Expense restated | Q2 2025 · Nov 30, 2023 | $422.34K |
| Sga Expense restated | Q2 2025 · Nov 30, 2023 | $800.29K |
| Net Income | Q2 2025 · Nov 30, 2023 | $1.02M |
| Net Income | Q2 2025 · Nov 30, 2023 | $1.17M |
| Operating Income | Q2 2025 · Nov 30, 2023 | $1.26M |
| Operating Income | Q2 2025 · Nov 30, 2023 | $1.44M |
| Gross Profit | Q2 2025 · Nov 30, 2023 | $6.26M |
| Gross Profit | Q2 2025 · Nov 30, 2023 | $10.91M |
| Revenue | Q2 2025 · Nov 30, 2023 | $8.42M |
| Revenue | Q2 2025 · Nov 30, 2023 | $14.53M |